Clinical Trial Update: Study to Evaluate the Effect of GBT440 Administered to Subjects With IPF on Supplemental Oxygen at Rest [Phase 2]

View source ↗

Summary

Phase 2 study evaluating GBT440 in subjects with idiopathic pulmonary fibrosis on supplemental oxygen was terminated; results posted in 2020.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Idiopathic Pulmonary Fibrosis

Drugs mentioned

• GBT440

Snippet

Sponsor: Global Blood Therapeutics | Conditions: Idiopathic Pulmonary Fibrosis, Hypoxemia | Phase 2 | Status: TERMINATED | Results posted: 2020-08-21